Login / Signup

A unique cytotoxic CD4 + T cell-signature defines critical COVID-19.

Sarah BairdCaroline L AshleyFelix Marsh-WakefieldSibel AlcaThomas Myles AshhurstAngela L FergusonHannah LukemanClaudio CounoupasJeffrey J PostPamela KonecnyAdam BartlettMarianne MartinelloRowena A BullAndrew LloydAlice GreyOwen HutchingsUmaimainthan PalendiraWarwick J BrittonMegan SteainJames A Triccas
Published in: Clinical & translational immunology (2023)
T-cell responses may contribute to cell-mediated host tissue damage and progression of COVID-19. Induction of these potentially detrimental T-cell responses should be considered when developing and implementing effective COVID-19 control strategies.
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus
  • stem cells
  • cell therapy
  • mesenchymal stem cells
  • quality improvement